HORIZON PHARMACEUTICAL LLC 8-K 2009
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 15, 2009
TORREYPINES THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
Registrants telephone number, including area code: (858) 623-5665
(Former Name or Former Address, if Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, Transfer of Listing
On July 15, 2009 TorreyPines Therapeutics, Inc. (the Company) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market notifying the Company that it did not comply with the minimum $10,000,000 stockholders equity requirement for continued listing set forth in Listing Rule 5450(b)(1)(A), prior to the expiration of the extension granted by the Staff on July 14, 2009. TorreyPines initially received notification from the Staff of its noncompliance with the minimum $10,000,000 stockholders equity requirement for continued listing on March 31, 2009.
The Company plans to request a hearing before the Nasdaq Listing Qualifications Panel to review the Staff determination to delist the Companys common stock. The request for a hearing will stay the Staff determination to delist the Companys common stock until the Panel renders a determination following the hearing. The hearing is expected to be scheduled within 30 to 45 days of the Companys request, which the Company submitted on July 21, 2009.
There can be no assurances that the Listing Qualifications Panel will grant the Companys request for continued listing on The Nasdaq Global Market, in which case the Companys common stock could be delisted from The Nasdaq Stock Market.
A copy of the press release is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits
(d) The following exhibit is furnished herewith:
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INDEX TO EXHIBITS